Table 7.
Group | n | VEGF | APP | α7-nAChRs | RAGE | LRP-1 |
---|---|---|---|---|---|---|
C57 sham-operated | 10 | 0.800±0.150 | 0.720±0.392 | 1.200±0.291 | 1.090±0.392 | 1.160±0.713 |
C57 ischemia | 10 | 1.450±0.730a | 0.680±5.254 | 1.120±3.022 | 0.730±2.991 | 1.570±0.959a |
APP/PS1 model | 10 | 0.180±0.080a | 1.070±0.045a | 0.190±0.040a | 2.090±0.031a | 0.380±0.191a |
APP/PS1 ischemia | 10 | 0.540±0.481a | 2.730±1.132a | 0.320±0.903a | 2.670±0.675a | 0.850±1.052a |
C57BL ischaemic + aspirin | 10 | 0.860±0.421b | 0.680±5.250 | 0.400±0.212d | 0.480±0.214b | 1.380±2.053b |
C57BL ischaemic + SLT | 10 | 1.490±0.111 | 0.150±0.190d | 0.320±0.192d | 0.110±0.091d | 1.250±0.312c |
APP/PS1 + SLT | 10 | 0.630±0.450c | 0.580±0.626 | 0.700±0.580 | 0.501±0.455 | 1.680±0.523e |
APP/PS1 ischaemic + donepezil hydrochloride | 10 | 0.160±0.121 | 0.420±0.480 | 0.630±0.002 | 1.240±0.244 | 1.490±0.422e |
APP/PS1 ischaemic + SLT | 10 | 0.930±0.345c | 0.690±0.242 | 1.180±1.591 | 2.090±0.915 | 1.420±0.560e |
Notes: ischaemic treatment: both right and left common carotid arteries were separated, and the arterial blood vessel was stimulated with a temperature-controlled current of 80 mu A using an in vivo thrombometer to cause thrombosis. The APP/PS1 ischaemic + donepezil hydrochloride group were administered intragastrically with 20 mg·kg-1·d-1 of donepezil hydrochloride. The C57BL ischaemic + aspirin group were administered intragastrically with 32 mg·kg-1·d-1 of aspirin, the SLT group were administered intragastrically with 32 mg·kg-1·d-1 of SLT and the control group were given 32 mg·kg-1·d-1 of solvent. Duration: two months. SLT: Sailuotong; APP: amyloid precursor protein; PS1: presenilin-; VEGF: vascular endothelial growth factor; α7-nAChRs: α7-nicotinic acetylcholine receptor; RAGE: anti-receptor for advanced glycation endproducts; LRP-1: lipoprotein receptor-related-protein-1. One-way analysis of variance was employed to make comparisons among groups, and in the case of the normal distribution, Tukey’s post hoc test was conducted; otherwise, the Kruskal-Wallis test was adopted. Compared with C57 sham-operated group, aP < 0.05; compared with C57 ischemia group, bP < 0.05, dP < 0.01; compared with APP/PS1 ischemia group, cP < 0.05, eP < 0.01.